Nexstim Plc supports 10th International Symposium on Navigated Brain Stimulation in Neurosurgery and Neuromodulation

Helsinki, Finland: 28 September 2018 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic application, today announces its support for the 10th International Symposium on Navigated Brain Stimulation (NBS) which will be held on 12-13 October 2018 in Berlin, Germany.

The symposium attracts a wide international audience from Europe, US and Asia and provides an update on Navigated Transcranial Magnetic Stimulation (nTMS) for both therapy and brain mapping by leaders in their respective fields.

More info on Nexstim's website.

 


Next > Nexstim Plc launches presence in Asia with distribution agreement of its SmartFocus™ TMS system to access Hong Kong market

Previous > Mainstay Medical announces 2018 half-year financial results and update